Literature DB >> 21846944

NF-kB expression in IgA nephropathy outcome.

G E B Silva1, R S Costa, R C Ravinal, L Z Ramalho, M A Dos Reis, T M Coimbra, M Dantas.   

Abstract

Some studies have demonstrated the involvement of nuclear factor-kappa B (NF-kB) in the pathogenesis of glomerulonephritis. The aim of our study was twofold: (1) to analyze the prognostic value of NF-kB expression in primary IgA nephropathy (IgAN) and (2) to compare the results of NF-kB expression by immunohistochemistry (IHC) and southwestern histochemistry (SWH). We analyzed 62 patients diagnosed with IgAN from 1987 to 2003. We used monoclonal antibodies to CD68 and mast cell tryptase and polyclonal antibodies to TGF-β1, α-SMA and NF-kB p65. We used SWH for the in situ detection of activated NF-kB. The results showed that NF-kB expression (mainly by SWH) correlated with clinical and histological parameters. An unfavorable clinical course of IgAN was significantly related to tubular NF-kB expression by SWH, but not by IHC. The Kaplan-Meier curves demonstrated that increased NF-kB expression, which was measured by IHC and SWH, decreased renal survival. In conclusion, the increased expression of NF-kB in the tubular area may be a predictive factor for the poor prognosis of patients with IgAN. Compared with IHC, NF-kB expression determined by SWH was correlated with a larger number of parameters of poor disease outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846944      PMCID: PMC3826481          DOI: 10.3233/DMA-2011-0795

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  10 in total

1.  Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammation.

Authors:  Yanhong Wang; Jihua Tian; Haixiu Guo; Yang Mi; Ruijing Zhang; Rongshan Li
Journal:  Clin Exp Med       Date:  2015-04-28       Impact factor: 3.984

2.  Inhibitor of NFκB Kinase Subunit 2 Blockade Hinders the Initiation but Aggravates the Progression of Crescentic GN.

Authors:  Janine Gotot; Eveline Piotrowski; Martin S Otte; André P Tittel; Guo Linlin; Chen Yao; Karl Ziegelbauer; Ulf Panzer; Natalio Garbi; Christian Kurts; Friedrich Thaiss
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

3.  Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.

Authors:  Maria Teresa Rocchetti; Massimo Papale; Anna Maria d'Apollo; Ida Valentina Suriano; Anna Maria Di Palma; Grazia Vocino; Eustacchio Montemurno; Leonarda Varraso; Giuseppe Grandaliano; Salvatore Di Paolo; Loreto Gesualdo
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 8.237

4.  Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway.

Authors:  Kuo-Feng Hua; Shun-Min Yang; Tzu-Yang Kao; Jia-Ming Chang; Hui-Ling Chen; Yung-Jen Tsai; Ann Chen; Sung-Sen Yang; Louis Kuoping Chao; Shuk-Man Ka
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

5.  Effect of Vitamin D and Tacrolimus Combination Therapy on IgA Nephropathy.

Authors:  Dong Yuan; Zhan Fang; Fang Sun; Jing Chang; Jian Teng; Shuhua Lin; Xiaoming Liu
Journal:  Med Sci Monit       Date:  2017-06-29

Review 6.  NFκB and Kidney Injury.

Authors:  Ning Song; Friedrich Thaiss; Linlin Guo
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

7.  Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.

Authors:  Junjie Wang; Dongdong Fu; Soulixay Senouthai; Yanwu You
Journal:  Mol Med Rep       Date:  2019-10-09       Impact factor: 2.952

8.  Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy.

Authors:  Wai Han Yiu; Kam Wa Chan; Loretta Y Y Chan; Joseph C K Leung; Kar Neng Lai; Sydney C W Tang
Journal:  Front Physiol       Date:  2021-03-15       Impact factor: 4.566

Review 9.  NF-κB in inflammation and renal diseases.

Authors:  Haisong Zhang; Shao-Cong Sun
Journal:  Cell Biosci       Date:  2015-11-16       Impact factor: 7.133

Review 10.  NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes.

Authors:  Sachin V Suryavanshi; Yogesh A Kulkarni
Journal:  Front Pharmacol       Date:  2017-11-07       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.